Plain-English translation of NCT06076226 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying whether the age and health of stem cells donated by healthy donors can help predict how well acute leukemia patients recover after receiving a stem cell transplant. The study will look at blood samples collected from donors before their cells are used for transplant, and follow how well patients do over time. This could help doctors better understand which transplants are most likely to succeed.
Acute leukemia is a serious blood cancer, and stem cell transplants from healthy donors offer one of the best chances for a cure. However, not all transplants work equally well, and doctors don't yet fully understand which donor factors predict better outcomes. This study aims to fill that gap by examining whether certain characteristics of the donated cells can help predict success.
You likely qualify if…
You likely don't qualify if…
This is a retrospective study, meaning researchers will review medical records and blood samples that have already been collected from you and your donor during your transplant care — you won't need additional visits or procedures. Researchers will analyze your donor's blood sample (taken before transplant) and compare it with your transplant outcomes over time to see if donor cell health predicted how well you recovered. The study involves up to 2,500 patients across two hospitals in China.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
China